<DOC>
	<DOCNO>NCT02986672</DOCNO>
	<brief_summary>This study aim evaluate effect marine monounsaturated polyunsaturated fatty acid child age 6-13 year , ADHD/ADD relate symptom . The study randomize , double-blind placebo-control study include approximately 330 child Norway . The primary outcome measure ADHD core symptom report caregiver , teacher child 0 month ( baseline ) , 6 month ( end treatment ) 12 month ( 6 month post treatment ) . The secondary outcome measure read write disability , cognitive function , physical Health .</brief_summary>
	<brief_title>Intervention With Omega-3 Children With Attention Deficit Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description>Children ADHD show low blood level omega-3 fatty acid , relate diet . Low level omega-3 also directly relate poor cognition behavior . Trials show supplement omega-3 may improve literacy behavior child ADHD symptom . It also show improve memory reaction time . The effect size find meta analysis placebo- control clinical trial ADHD core symptom small modest . In study adolescent mental health North Norway 2003-2005 significant association find intake fish hyperactivity adolescent high intake show less hyperactivity peer low intake ( unpublished result The Norwegian Arctic Adolescent Health Study , Siv Kvernmo ) . There several key limitation exist study . Underpowered sample size , different methodology short intervention period factor raise question effect size . Other trial control group . We design study take limitation consideration . In addition use whole marine oil zooplankton Calanus finnmarchicus high natural content steardidonic acid 18:3 n-3 precursor EPA . The oil also high content astaxanthines - natural antioxidant . Earlier clinical study use pure oil zooplankton Calanus finnmarchicus . The oil process chemically ethylation , alter structure oil , also devoids product natural antioxidant .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<criteria>ADHD ADD accord DSMIV criterion IQ 70 infantil autism , psychosis , bipolar disorder serious somatic disease abnormal pathological blood test trial Omega3 supplement take 3 month inclusion</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>13 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>ADHD</keyword>
	<keyword>omega 3</keyword>
	<keyword>child</keyword>
	<keyword>nutrition</keyword>
	<keyword>MUFA</keyword>
	<keyword>ADD</keyword>
	<keyword>PUFA</keyword>
	<keyword>Calanus</keyword>
	<keyword>learn difficulty</keyword>
</DOC>